The Selvax Project
Immunological Based Treatment
Selvax Immune is a research group led by Curtin University immunologist Dr Delia Nelson. The team is researching an immunological based approach to the treatment of large solid cancerous tumours.
Selvax has made encouraging progress in the treatment of large solid tumours in animals by administration of selected immunological agents into the tumour micro environment. The technology has achieved cancer clearance rates in the range of 60%- 80% in repeated small animal studies for a range of solid tumours and has shown the capacity to protect against recurrence of the cancer.
Media on Mars worked with the group to create a website to promote this important research.